Information on Zantac Lawsuits in New JerseyNew Jersey Legal News
FDA Enacts Recall of All Brand Name Zantac Products
The US Food and Drug Administration (FDA) enacted a recall on all prescription and over-the-counter ranitidine — more commonly known as Zantac — products effective April 1, 2020, requiring that all products be withdrawn from the market immediately.
Zantac belongs to a class of drugs referred to as H2 blockers. Zantac was primarily used to prevent and treat heartburn, acid reflux, and other symptoms caused by excess acid produced in the stomach.
New Findings Reveal Unsafe Levels of N-Nitrosodimethylamine (NDMA)
This request from the FDA to immediately recall the drug was based on findings that certain ranitidine products contained N-Nitrosodimethylamine (NDMA), which has been classified as a likely human carcinogen. Testing has ultimately determined that under certain circumstances NDMA levels in ranitidine products can increase under typical storage conditions. According to recent research, NDMA levels increase significantly when stored at higher temperatures and over time.
Connections have been found between NDMA and certain cancers including:
- Bladder Cancer
- Kidney (Renal) Cancer
- Pancreatic Cancer
- Stomach Cancer
- Colorectal Cancer
- Liver Cancer
- And other Cancers
If You Have Developed Cancer After Taking Zantac, Our New Jersey Attorneys Can Help
If you or a family member has taken a prescription or over-the-counter ranitidine product, such as Zantac, continuously for one month or more and then developed cancer, you may be able to entitled to deserved compensation. Discuss your case with a Zantac personal injury lawyer in New Jersey at Brady, Brady, & Reilly, LLC today so you can understand your legal options.
New Jersey Zantac Personal Injury
Multiple studies have found a connection between Zantac and various cancers. These studies were conducted by professionals and were closely monitored and control, giving their findings a significant level of legitimacy. For anyone who has taken Zantac or other products containing NDMA in the past, it’s natural to be worried. If you or a loved one has developed cancer after taking a similar product, you should consult with a qualified personal injury attorney in order to better understand your legal options for compensation.
All drug recalls and possible recalls can be a cause for concern. One of this magnitude can be particularly distressing because it involves medicine, which is available for purchase without the need of a prescription. In the past, some have criticized the FDA for its failure to recall the drug officially, making this recall even more concerning.
Brady, Brady, & Reilly, LLC has a history of holding pharmaceutical companies accountable for their actions. If you believe you or a loved one developed cancer due to taking Zantac, we’re prepared to help you fight for the compensation you deserve. Our legal team is already representing those who have developed cancer while taking Zantac and other ranitidine products. Give us a call today at (201) 997- 0030 to discuss your case with a qualified New Jersey personal injury lawyer. We believe that pharmaceutical companies should be held accountable when their products result in the harm of their consumers.